![Gary Pace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Pace
Directeur/Membre du Conseil chez
CARDIFF ONCOLOGY, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Gary W.
Pace was the founder of Transcend Therapeutics, Inc., founded in 1992, and Sova Pharmaceuticals, Inc., founded in 2010, where he served as Director in 2010.
Current jobs include Executive Chairman at View Point Medical, Inc.; Director at Protiveris, Inc., NeuroMedix, Inc., Sacron Innovations Pty Ltd., Upstream Medical Technologies Ltd., Immunicom, Inc., Curtana Pharmaceuticals, Inc.; Professor at The University of Queensland; Independent Director at Cardiff Oncology, Inc. since 2020; and Partner & Investment Committee Chair at Pacific Channel Ltd. since 2010.
Former jobs include Chairman & Chief Executive Officer at Waratah Pharmaceuticals, Inc. (2000–2002); President & Chief Executive Officer at SkyePharma Canada, Inc. (1995–2001); Vice Chairman at Hunter Immunology Pty Ltd.; Independent Director at ResMed, Inc. (1994–2018); Director at Imunon, Inc. (2002–2010); Independent Director at Transition Therapeutics, Inc. (2002–2018); Independent Non-Executive Director at Percheron Therapeutics Ltd. (2015–2022); Director at Peplin Ltd. (2009); Independent Non-Executive Director at Guardian Medical Solutions Ltd. (2001–2013); Director at Peplin, Inc. (2004–2009); Independent Non-Executive Director at Invitrocue Ltd. (2018–2019); Director at Breathe Easy Ltd.; Independent Non-Executive Director at Simavita Ltd. (2016–2021); Director at Footfalls & Heartbeats (UK) Ltd. (2013–2015); Director at AVACEN, Inc.; Director at Engender Technologies Ltd.; Independent Director at Pacira Biosciences, Inc. (2008–2024); and Senior Vice President-Research & Development at Clintec International, Inc. (Illinois) (1989–1993).
Education includes a doctorate from Massachusetts Institute of Technology conferred in 1975 and an undergraduate degree from The University of New South Wales conferred in 1974.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 1 326 376 ( 1,94% ) | 3 M $ | 31/05/2026 |
Postes actifs de Gary Pace
| Sociétés | Poste | Début |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/04/2020 |
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Develops biomarker-based testing for diagnoses of heart disease and associated clinical complications | Directeur/Membre du Conseil | - |
Curtana Pharmaceuticals, Inc.
 Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Directeur/Membre du Conseil | - |
View Point Medical, Inc.
 View Point Medical, Inc. Medical SpecialtiesHealth Technology Manufactures one mark detection imaging system and tissue markers | Président | - |
Immunicom, Inc.
 Immunicom, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for immunotherapy | Directeur/Membre du Conseil | - |
Sacron Innovations Pty Ltd. | Directeur/Membre du Conseil | - |
Protiveris, Inc.
 Protiveris, Inc. Information Technology ServicesTechnology Services Provides an IT, software and business services | Directeur/Membre du Conseil | - |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Gary Pace
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Gary Pace
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
ResMed, Inc.
 ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Protiveris, Inc.
Protiveris, Inc. Information Technology ServicesTechnology Services Provides an IT, software and business services | Technology Services |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Develops human therapeutic products for the treatment of cancer | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guardian Medical Solutions Ltd.
 Guardian Medical Solutions Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceutical products for pain management and central nervous system disorders | Health Technology |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Provides bio analytic solutions | Health Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Clintec International, Inc. (Illinois)
 Clintec International, Inc. (Illinois) Pharmaceuticals: MajorHealth Technology Pharmaceuticals | Health Technology |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Improves the solubility of drugs via nano-particulate technology | Commercial Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hunter Immunology Pty Ltd.
 Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Develops immune modulators for treatment of respiratory diseases | Health Technology |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of human therapeutic drugs | Health Technology |
Breathe Easy Ltd.
 Breathe Easy Ltd. Medical/Nursing ServicesHealth Services Develops drug for cystic fibrosis | Health Services |
Pacific Channel Ltd.
 Pacific Channel Ltd. Investment ManagersFinance Pacific Channel invests in companies located in Australia, New Zealand, Singapore and in the United States. The firm targets companies operating in the field of deep technology, health, environment and ag/food sectors. It provides financing for pre-seed and early stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
Sacron Innovations Pty Ltd. | |
Simavita Ltd.
 Simavita Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops and markets wearable & disposable sensors for the health care industry | Electronic Technology |
Footfalls & Heartbeats (UK) Ltd.
 Footfalls & Heartbeats (UK) Ltd. TextilesProcess Industries Designs, develops, and manufactures smart textiles | Process Industries |
AVACEN, Inc.
 AVACEN, Inc. Medical SpecialtiesHealth Technology Develops pain relief medical devices | Health Technology |
Engender Technologies Ltd.
 Engender Technologies Ltd. Medical/Nursing ServicesHealth Services Develops proprietary process to separate bearing bull sperm cells | Health Services |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Develops biomarker-based testing for diagnoses of heart disease and associated clinical complications | Health Technology |
View Point Medical, Inc.
View Point Medical, Inc. Medical SpecialtiesHealth Technology Manufactures one mark detection imaging system and tissue markers | Health Technology |
Immunicom, Inc.
Immunicom, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for immunotherapy | Health Technology |
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Health Technology |
